CAR T-Cell Therapy an Emerging Explosion in Myeloma Paradigm – OncLive
|
CAR T-Cell Therapy an Emerging Explosion in Myeloma Paradigm
OncLive There are T-cell receptor (TCR) therapies, such as NY-ESO-1, and there are several clinical trials for this, one of which we are going to be participating in at UCSF. In addition, we talked about the exciting data with CAR T cells. This is exciting … |
